Navigation Links
Light touch: Controlling the behavior of quantum dots
Date:8/19/2008

team uses lasers to precisely control the energy levels of quantum dots, just as physicists have been doing with actual single atoms since the mid-1970s and, much more recently, with the artificial quantum dot variety. With their customized set-up, which includes two lasersone shining from above the quantum dot and the other illuminating it from the sidethe researchers were able to manipulate energy states in a quantum dot and directly measure its emissions. By adjusting the intensity of the laser beams, they were able to correct for imperfection-caused variations and generate more ideal signals. In so doing, the team was the first to demonstrate that laser-tuned quantum dots can efficiently generate photons one at a time, as required for quantum cryptography and other applications.

While the device currently still requires quite cold temperatures and sits in a liquid helium bath, it is compact enough to fit in the palm of your handan elegant setup that could be eventually implemented in quantum cryptography applications.


'/>"/>

Contact: Mark Bello
mark.bello@nist.gov
301-975-3776
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
3. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
4. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
5. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
6. Access Highlighted in Recent BusinessWeek Article
7. Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
8. Highlights of Economic and Business Growth in the Tampa Bay Region
9. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
10. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
11. CU researchers shed light on light-emitting nanodevice

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Light touch: Controlling the behavior of quantum dots
Light touch: Controlling the behavior of quantum dots
(Date:11/20/2009)... METTLER TOLEDO recently announced that a ...timization Using At-Line Particle Characterization...n this webinar, the application of in situ particl...gn space and optimize a series of roller compactio...d roller compaction forces. , ...
(Date:11/19/2009)...ould like to be able to charge their cell phones a...often. A recent discovery made by UC San Diego eng...pacitors that could do just this. , In recent r...rabhakar Bandaru, a professor in the UCSD Departme...with graduate student Mark Hoefer, have found that...
(Date:11/19/2009)...E, Nov. 19 Omeros Corpor...inancial results for the third quarter ended Septe...r 30, 2009, Omeros reported a net loss of $3.9 mil...s of $7.4 million, or $2.54 per share, for the sam...ber 30, 2009, the Company reported a net loss of $...
(Date:11/19/2009)...,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall...ovator in biotechnology for diabetes therapy, and ...services to food, supplement, biotechnology and ph...the previously reported $6.3 million registered di...,870 shares of its common stock and warrants to pu...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...on,(Nasdaq: RGEN ) announced today that the Compa.... Herlihy, Ph.D., will present at the 2008 UBS,Glo...er 24, 2008 at 1:00,p.m. EDT at the Grand Hyatt Ho...dio-webcast of the presentation will be available ... and will be archived for 30 days,following the p...
...daq: DNDN ) today announced that Mitchell H. Gold...endreon, will present a company update at the,UBS ...on Monday, September,22, 2008 at 1:30 p.m. ET., A...cessible through the,Investor Relations section of...f you are unable to listen to the live webcast,it ...
...ositions company as it expands its ...Calif., Sept. 17 Tethys Bioscience, Inc.,announce... of West,Sacramento, Calif. The acquisition will b...sing conditions. Financial terms were not disclose...abolite profiling,technology with Tethys, proven e...
Other Biology Technology:Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 2Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 3Tethys Bioscience Announces Acquisition of Lipomics Technologies 2Tethys Bioscience Announces Acquisition of Lipomics Technologies 3
(Date:11/19/2009)... with an unwieldy name: 4-hydroxybutyrate (4-HB). ...-rape drug. , Now, a team of Ohio and Michigan ...B is metabolized by the body. "This is new and imp...ssor and chair of biological sciences at Michigan ...rch team. "It may provide new clues on how to cou...
(Date:11/19/2009)...ing the genetic instructions inside corn, one of t... of the most complex sequences of DNA ever analyze... David Schwartz, who was one of more than 100 auth...The maize genome is a true maze full of confusing... sequencers for years," says Schwartz. , Publica...
(Date:11/19/2009)...ulti-institutional effort co-led by three Cold Spr... today in publication of a landmark series of pape...nted detail the DNA sequence of maize ( Zea mays )...h American consumers, is one of the world,s most i... crop grown in the United States, representing $47...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 1Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 2Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 3Blood Mercury Levels Rising Among U S Women 55169 1Blood Mercury Levels Rising Among U S Women 55169 2FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 1FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 2FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 3FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 4FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 5FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 6FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 7FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 8FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 9FDA Approves XYZAL 28R 29 For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 55166 10
...k species, there seems to be super-sized confusion...at the University of New Hampshire, one thing is c...ish shark populations in the past two decades. ,... many of the three-foot-long sharks that the yello...However, fishery management plans have set quotas ...
... know that the mental clarity lost because of a fe...od night,s rest. Now, UT Southwestern Medical Cent...hanism that regulates the brain,s ability to menta...with mice, they found that a molecule called an ad... animals to attain adequate levels of slow-wave ac...
...nd security, law enforcement and other first-respo...ing encouraged to attend the 2009 Force Protection...rginia this May 19-21. , , Nearly 600 exhibits wi...t, just south of Marine Corps Base, Quantico, VA. ...demonstrations will be at ranges on the Marine Cor...
Other Biology News:UNH researchers studying spiny dogfish, Gulf of Maine's mini shark 2UNH researchers studying spiny dogfish, Gulf of Maine's mini shark 3UT Southwestern researchers identify molecule that helps the sleep-deprived to mentally rebound 2Demonstration Targets Terrorism 2
Goat Anti-DRAK 2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...tain a proprietary high-performance desalting resi...salting and protein-recovery characteristics compa...s containing as low as 25 g/ml of protein can be p...nd > 95% retention of salts and other small molecu...
... antibody detects an ~185 kDa protein, correspondi...orylated at tyrosine 1248 on SDS-PAGE immunoblots....rbed against the non-phosphorylated peptide to rem...ted form of the protein. In cell lines where EGFR...
Biology Products: